SEARCH RESULTS FOR:
Dr. Ross Sherlock
PROFESSOR, DIRECTOR OF MERC AND METAL EARTH, CHAIR IN EXPLORATION TARGETING, LAURENTIAN UNIVERSITY
The Mineral Exploration Research Centre (MERC) is a part of the Harquail School of Earth Sciences (HES) at Laurentian University in Sudbury, Ontario.
Ese Avanoma
GROUP MANAGING DIRECTOR, BRADE GROUP
BRADE was established in 2012 and currently has offices in Nigeria, Ghana and Uganda. The company offers a wide array of services to the African market ranging from energy services solutions, chemical solutions to manufacturing.
Carla Martínez
GENERAL MANAGER, CANADA PERU CHAMBER OF COMMERCE (CCCP)
A discussion about the challenges and opportunities for Canadian investors in Peru’s mining industry.
Paolo Russolo
PRESIDENT, ASCHIMFARMA
Aschimfarma represents Italian producers of pharmaceutical ingredients and helps advise them on regulations across the world.
Jose Vizquerra
CEO & DIRECTOR, O3 MINING INC.
O3 holds a unique portfolio of assets in Quebec and Ontario and which it is exploring.
A West-Meets-East Of The Pharma Industry
Turkey Pharmaceuticals & Biopharmaceuticals 2020
Portrait of the Turkey Pharmaceuticals industry.
Ersin Erfa
GENERAL MANAGER, CENTURION PHARMA
Centurion Pharma was founded in 1979, and today imports products for the treatment of rare diseases as well as biological, biotechnological and hospital products. Centurion has also taken steps to develop and manufacture products locally by establishing an R&D Department in 2011.
Dr. Ayça Sezer
MANAGING DIRECTOR, CORPORATE BUSINESS DEVELOPMENT DIRECTOR, SANTA FARMA
Santa Farma was established in 1944 and has become known as a leading company capable of manufacturing the highest volume in a single shift in Turkey.
Michael Gribbons
CO-FOUNDER AND VICE PRESIDENT – SALES & MARKETING, MAESTRO DIGITAL MINE
Maestro Digital Mine discusses its latest innovations, and which factors are generating demand.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
